Literature DB >> 7543187

Adenosine receptors mediate both contractile and relaxant effects of adenosine in main pulmonary artery of guinea pigs.

A J Szentmiklósi1, A Ujfalusi, A Cseppentö, K Nosztray, P Kovács, J Z Szabó.   

Abstract

In guinea pig main pulmonary artery precontracted with noradrenaline, adenosine exerted an initial phasic contraction followed by a tonic contraction and a slow relaxation. After selective blockade by 1,3-dipropyl-8-cyclopentylxanthine (DPCPX: 10 nM) of A1 receptors, adenosine only elicited a rapid relaxation. This initial response was characterized by use of adenosine (AR) and its analogues N6-cyclopentyl-adenosine (CPA), R-N6-phenylisopropyladenosine (R-PIA), 2-chloroadenosine (CADO), 5'-N-ethyl-carboxamidoadenosine(NECA), N6-2-(4-aminophenyl) ethyl adenosine (APNEA) and 2-p-((carboxyethyl)-phenethylamino)-5'-carboxamidoadenosine (CGS 21 680). The order of potency of the adenosine analogues for purine-induced phasic contraction was CPA > R-PIA > NECA = APNEA > AR > CGS 21 680 suggesting the involvement of activation of A1 type adenosine receptors in the contraction phase. DPCPX antagonized the CPA-induced contraction with a pA2 = 9.27 +/- 0.26, but the Schild plot slope parameter was significantly lower than unity (0.58 +/- 0.09). In contrast, in electrically driven guinea pig atrial myocardium (a tissue reported to possess A1 receptors), the DPCPX-CPA antagonism was purely competitive (pA2 = 8.95 +/- 0.06; slope = 0.93 +/- 0.06). In the presence of 300 nM DPCPX, the rank order of potency for the purine-induced fast relaxation was NECA > CADO = AR > CGS 21 680 = R-PIA > CPA. The NECA- and adenosine-induced relaxation was influenced neither by 300 nM CP 66713 (an antagonist at A2a receptors), nor by endothelial removal and inhibition of nitric oxide synthase (100 microM NG-nitro-L-arginine: L-NOARG).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7543187     DOI: 10.1007/bf00169083

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  41 in total

1.  N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists.

Authors:  W H Moos; D S Szotek; R F Bruns
Journal:  J Med Chem       Date:  1985-10       Impact factor: 7.446

2.  Evidence for an A1-adenosine receptor in the guinea-pig atrium.

Authors:  M G Collis
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

3.  Adenosine enhancement of adrenergic neuroeffector transmission in guinea-pig pulmonary artery.

Authors:  N P Wiklund; B Cederqvist; L E Gustafsson
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

4.  Characterization of P1-purinoceptors on rat duodenum and urinary bladder.

Authors:  J Nicholls; S M Hourani; I Kitchen
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

5.  Effects of adenosine receptor agonists in the isolated, perfused rat kidney.

Authors:  R D Murray; P C Churchill
Journal:  Am J Physiol       Date:  1984-09

6.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.

Authors:  P K Moore; O A al-Swayeh; N W Chong; R A Evans; A Gibson
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

8.  A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat.

Authors:  J P Hannon; H J Pfannkuche; J R Fozard
Journal:  Br J Pharmacol       Date:  1995-07       Impact factor: 8.739

9.  Almitrine bismesylate modulates the susceptibility of guinea pig pulmonary artery to catecholamines, PGF2 alpha and adenosine.

Authors:  R Behm; A J Szentmiklósi; A Cseppentö; J Szegi
Journal:  Biomed Biochim Acta       Date:  1987

10.  Xanthine derivatives as antagonists at A1 and A2 adenosine receptors.

Authors:  U Schwabe; D Ukena; M J Lohse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

View more
  5 in total

1.  Role of K+ channels in A2A adenosine receptor-mediated dilation of the pressurized renal arcuate artery.

Authors:  H M Prior; M S Yates; D J Beech
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

Review 2.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 3.  Adenosine A₂a receptors and O₂ sensing in development.

Authors:  Brian J Koos
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

4.  Adenosine-mediated hypotension in in vivo guinea-pig: receptors involved and role of NO.

Authors:  P Nieri; E Martinotti; V Calderone; M C Breschi
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

Review 5.  Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development.

Authors:  Chrisna Matthee; Gisella Terre'Blanche; Lesetja J Legoabe; Helena D Janse van Rensburg
Journal:  Mol Divers       Date:  2021-06-27       Impact factor: 3.364

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.